Patents/Assignees

Allergan, Inc.

20 patents in portfolio

US12599699utility2026
Co-crosslinked Hyaluronic Acid-silk Fibroin Hydrogels for Improving Tissue Graft Viability and for Soft Tissue Augmentation
0 cites
US12527816utility2026
Sodium Chlorite Compositions with Enhanced Anti-microbial Efficacy and Reduced Toxicity
0 cites
US12409211utility2025
Non-protein Clostridial Toxin Compositions
0 cites
US12241098utility2025
Process and System for Obtaining Botulinum Neurotoxin
0 cites
US12208155utility2025
Method for Improving Duration of Effect of Dermal Filler Treatment
0 cites
US12171816utility2024
Non-protein Clostridial Toxin Compositions
0 cites
US12144847utility2024
Non-protein Clostridial Toxin Compositions
0 cites
US12004995utility2024
Intraocular Implant with High Loading of a Prostamide
0 cites
US11992668utility2024
Injection Device
0 cites
USD1027647design2024
Bottle Holder
0 cites
US11944533utility2024
Implantable Prostheses for Tissue Expansion
0 cites
US11890457utility2024
Aspiration and Injection Device
0 cites
US11844878utility2023
Crosslinked Hyaluronic Acid-collagen Gels for Improving Tissue Graft Viability and Soft Tissue Augmentation
0 cites
US11833269utility2023
Hyaluronic Acid-collagen Matrices for Dermal Filling and Volumizing Applications
0 cites
US11819541utility2023
Injection Paradigm for Administration of Botulinum Toxins
0 cites
US11738043utility2023
Sodium Chlorite Compositions with Enhanced Antimicrobial Efficacy and Reduced Toxicity
0 cites
US11684719utility2023
Methods of Treatment Using a Syringe Extrusion Accessory
0 cites
US11648104utility2023
Implant Identification by Radiographic Means
0 cites
USD0977647design2023
Tissue Expansion Device
0 cites
US8343949utility2013
Stabilized Compositions Comprising a Therapeutically Active Agent, and an Oxidizing Preservative
0 cites